Breelyn Wilky, MD, explains when patients with gastrointestinal stromal tumor should be referred for clinical trials.
Breelyn Wilky, MD
Breelyn Wilky, MD, is the director of Sarcoma Medical Oncology at the University of Colorado Anschutz Medical Campus in Aurora, Colorado.
Articles by Breelyn Wilky, MD
Breelyn Wilky, MD, discusses what key molecular insights in GIST management community oncologists should prioritize today.
Breelyn Wilky, MD, discusses what precision oncology advancements will most impact gastrointestinal stromal tumor management in the next 3 to 5 years.